- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Anti-CTLA-4
Total 105643 results
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Puerto Rico
-
Stanford UniversityAstraZenecaTerminatedBladder Adenocarcinoma | Bladder Mixed Adenocarcinoma | Bladder Squamous Cell Carcinoma | Infiltrating Bladder Urothelial Carcinoma With Giant Cells | Infiltrating Bladder Urothelial Carcinoma, Nested Variant | Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant | Bladder Urothelial... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI); SWOG Cancer Research NetworkCompletedSarcomaUnited States, Canada, Australia, Switzerland, Puerto Rico, Netherlands, New Zealand
-
Australasian Gastro-Intestinal Trials GroupNational Health and Medical Research Council, Australia; European Organisation... and other collaboratorsActive, not recruitingGastric CancerAustralia, New Zealand
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | B-cell Adult Acute Lymphoblastic Leukemia | T-cell Adult Acute Lymphoblastic LeukemiaUnited States
-
Cancer Research UKUnknown
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...Unknown
-
ETOP IBCSG Partners FoundationCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingNeurofibromatosis Type 1 | Metastatic Malignant Peripheral Nerve Sheath Tumor | Recurrent Malignant Peripheral Nerve Sheath TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
ImmunityBio, Inc.WithdrawnTriple Negative Breast Cancer (TNBC)United States
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.TerminatedPeripheral T Cell Lymphoma | Treatment-naïveChina
-
National Cancer Institute (NCI)RecruitingLymphoplasmacytic Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Grade 3b Follicular... and other conditionsUnited States
-
Hoffmann-La RocheActive, not recruitingCancerUnited States, Canada, France, Italy, Slovenia, Spain, Turkey, United Kingdom, Argentina, Brazil, Poland, Australia, Czechia, Thailand, Korea, Republic of, Russian Federation, Switzerland, Japan, Taiwan, Austria, Belgium, Portugal, ... and more
-
AVEO Pharmaceuticals, Inc.Bristol-Myers Squibb; ParexelActive, not recruitingRenal Cell CarcinomaCanada, Italy, Spain, United States, United Kingdom, Australia, Germany, Poland, Belgium, Portugal, Czechia, Brazil, France, Argentina, Chile, Mexico
-
Boehringer IngelheimActive, not recruitingHeart FailureCzechia, Switzerland, Poland, Hungary, Romania, Bulgaria
-
AllerganCompletedChronic MigraineUnited States, Australia, Canada, China, Czechia, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Spain, Sweden, Taiwan, United Kingdom
-
Novartis PharmaceuticalsCompletedBreast CancerChina, United States, France, Italy, United Kingdom, Taiwan, Turkey, Egypt, Germany, Hong Kong, Belgium, Canada, Russian Federation, Lebanon, Japan, Australia, Greece, Korea, Republic of, Ireland, Peru, Argentina, Brazil, Colombia, South... and more
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Immunomolecular Therapeutics, Inc.WCCT GlobalCompletedType1 DiabetesUnited States
-
Alison WalkerNovartis; Millennium Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid... and other conditionsUnited States
-
The First Affiliated Hospital with Nanjing Medical...Huai'an First People's Hospital; Yancheng First People's HospitalRecruitingAcute Myeloid LeukemiaChina
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecruitingCardiovascular Diseases | Vascular Diseases | HypertensionUnited Kingdom
-
George Medicines PTY LimitedCompletedHypertensionAustralia, United States, United Kingdom, Poland, Sri Lanka, New Zealand, Czechia
-
Vejle HospitalCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedThyroid Gland Undifferentiated (Anaplastic) CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnUnresectable Extrahepatic Bile Duct Carcinoma | Recurrent Cholangiocarcinoma | Non-Resectable Cholangiocarcinoma | Stage III Intrahepatic Cholangiocarcinoma | Stage IIIA Hilar Cholangiocarcinoma | Stage IIIB Hilar Cholangiocarcinoma | Stage IVA Hilar Cholangiocarcinoma | Stage IVA Intrahepatic Cholangiocarcinoma and other conditionsUnited States
-
Mayo ClinicRecruitingGastric Adenocarcinoma | Clinical Stage IV Gastric Cancer AJCC v8 | Gastroesophageal Junction Adenocarcinoma | Metastatic Gastric Carcinoma | Metastatic Malignant Neoplasm in the PeritoneumUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSecondary MyelofibrosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Hematopoietic Cell Transplantation RecipientUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic SyndromeUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedHigh Grade Upper Tract Urothelial CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Georgetown UniversityNational Institute of Mental Health (NIMH); Washington D.C. Veterans Affairs...CompletedSchizophreniaUnited States
-
Gesellschaft fur Padiatrische Onkologie und Hamatologie...UnknownBrain and Central Nervous System TumorsUnited States
-
Oregon Health and Science UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting
-
University of WashingtonNational Cancer Institute (NCI)CompletedMetastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Hormone-Resistant Prostate Cancer | Stage IV Prostate AdenocarcinomaUnited States
-
Hospital for Special Surgery, New YorkCompletedTotal Hip ReplacementUnited States
-
LEO PharmaCompleted
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
Astellas Pharma Global Development, Inc.Completed
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnInfiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Stage III Bladder Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnn Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Ann Arbor Stage II Non-Hodgkin LymphomaUnited States